Literature DB >> 18059366

Off the beaten pathway: the complex cross talk between Notch and NF-kappaB.

Clodia Osipo1, Todd E Golde, Barbara A Osborne, Lucio A Miele.   

Abstract

The canonical Notch pathway that has been well characterized over the past 25 years is relatively simple compared to the plethora of recently published data suggesting non-canonical signaling mechanisms and cross talk with other pathways. The manner in which other pathways cross talk with Notch signaling appears to be extraordinarily complex and, not surprisingly, context-dependent. While the physiological relevance of many of these interactions remains to be established, there is little doubt that Notch signaling is integrated with numerous other pathways in ways that appear increasingly complex. Among the most intricate cross talks described for Notch is its interaction with the NF-kappaB pathway, another major cell fate regulatory network involved in development, immunity, and cancer. Numerous reports over the last 11 years have described multiple cross talk mechanisms between Notch and NF-kappaB in diverse experimental models. This article will provide a brief overview of the published evidence for Notch-NF-kappaB cross talk, focusing on vertebrate systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059366     DOI: 10.1038/labinvest.3700700

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  110 in total

1.  Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29.

Authors:  Hui Li; Emilia Solomon; Sara Duhachek Muggy; Danqiong Sun; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Notch signalling pathway in tooth development and adult dental cells.

Authors:  X Cai; P Gong; Y Huang; Y Lin
Journal:  Cell Prolif       Date:  2011-10-04       Impact factor: 6.831

3.  Notch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survival.

Authors:  Lakshmi R Perumalsamy; Manjula Nagala; Apurva Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-25       Impact factor: 11.205

Review 4.  Targeting Notch to target cancer stem cells.

Authors:  Antonio Pannuti; Kimberly Foreman; Paola Rizzo; Clodia Osipo; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

5.  Adult epidermal Notch activity induces dermal accumulation of T cells and neural crest derivatives through upregulation of jagged 1.

Authors:  Carrie A Ambler; Fiona M Watt
Journal:  Development       Date:  2010-11       Impact factor: 6.868

6.  DAPT protects brain against cerebral ischemia by down-regulating the expression of Notch 1 and nuclear factor κB in rats.

Authors:  Shuya Li; Xiangjian Zyang; Yongjun Wang; Hui Ji; Yuanyuan Du; Haichao Liu
Journal:  Neurol Sci       Date:  2012-12       Impact factor: 3.307

7.  Bruceantin inhibits multiple myeloma cancer stem cell proliferation.

Authors:  Mark E Issa; Sarah Berndt; Gilles Carpentier; John M Pezzuto; Muriel Cuendet
Journal:  Cancer Biol Ther       Date:  2016-07-19       Impact factor: 4.742

Review 8.  Expanding role of delta-like 4 mediated notch signaling in cardiovascular and metabolic diseases.

Authors:  Daiju Fukuda; Masanori Aikawa
Journal:  Circ J       Date:  2013-09-12       Impact factor: 2.993

Review 9.  Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia.

Authors:  Teresa Palomero; Adolfo Ferrando
Journal:  Clin Lymphoma Myeloma       Date:  2009

Review 10.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.